MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$276,576K Prepaid expenses andother current assets$5,225K Restricted cash$449K Property, plant andequipment, gross$11,424K Total current assets$282,250K Operating leaseright-of-use assets$9,155K Property, plant andequipment, net$6,450K Restricted cash$2,315K Other non-currentassets$181K Accumulated depreciation$4,974K Total assets$300,351K Total liabilities andstockholders' equity$300,351K Total stockholders'equity$211,944K Total liabilities$88,407K Accumulated deficit-$753,710K Additional paid-in capital$964,666K Term loan, net$48,961K Total currentliabilities$20,098K Operating leaseliability, net of current...$17,766K Other non-currentliabilities$1,582K Accumulated othercomprehensive income (loss)$985K Common stock, 0.00001par value per share...$3K Accrued expenses andother current...$15,534K Accounts payable$4,564K
Balance Sheet

Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies, Inc. (TSHA)

source: myfinsight.com